Meeting
2021 ASCO Annual Meeting
Real-world outcomes of breast cancer patients with brain metastases treated with radiotherapy in Ontario: A population-based study.
Authors
Katarzyna Joanna Jerzak
University of Toronto, Toronto, ON, Canada
Katarzyna Joanna Jerzak , Michael Rosen , Xin Y Wang , Rania Chehade , Bo Zhang , Refik Saskin , Sunit Das , Hany Soliman , Arjun Sahgal , Kelvin K. Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2027)
DOI
10.1200/JCO.2021.39.15_suppl.2027
Abstract #
2027
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases: 3-year follow-up results from the phase 2 PERMEATE trial.
First Author: Min Yan
Poster
2020 ASCO Virtual Scientific Program
Systemic therapy for patients with breast cancer and one to three brain metastases (BM).
First Author: Zaid A Soomro
Poster
2016 ASCO Annual Meeting
T-DM1 to induce response in central nervous system (CNS) metastases from Her2 +ve metastatic breast cancer (MBC).
First Author: Yamini McCABE
Poster
2024 ASCO Genitourinary Cancers Symposium
Does use of apalutamide enhance outcomes in combination with radiotherapy in metastatic hormone-sensitive prostate cancer? A real-world experience from the UK.
First Author: Prantik Das